Michaela Reissland

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Dna Damage Response

Top Venues

Cell death and differentiation

Cell death & disease

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Rostislav Novak, Yamen Abu Ahmad, Michael Timaner, Eliya Bitman-Lotan, Avital Oknin-Vaisman, Roi Horwitz, Oliver Hartmann, Michaela Reissland, Viktoria Buck, Mathias T Rosenfeldt, David Nikomarov, Markus Elmar Diefenbacher, Yuval Shaked, Amir Orian
RNF4~RGMb~BMP6 axis required for osteogenic differentiation and cancer cell survival. Cell death & disease 13 (9) (2022)
Cristian Prieto-Garcia, Oliver Hartmann, Michaela Reissland, Fabian Braun, Süleyman Bozkurt, Nikolett Pahor, Carmina Fuss, Andreas Schirbel, Christina Schülein-Völk, Alexander Buchberger, Marco A Calzado Canale, Mathias Rosenfeldt, Ivan Đikić, Christian Münch, Markus Elmar Diefenbacher
USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K. Molecular oncology 16 (17) (2022)
Cristian Prieto-Garcia, Oliver Hartmann, Michaela Reissland, Thomas Fischer, Carina R Maier, Mathias T Rosenfeldt, Christina Schülein-Völk, Kevin Klann, Reinhard Kalb, Ivan Đikić, Christian Münch, Markus Elmar Diefenbacher
Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway. Cell death and differentiation (2021)